首頁 > 市場調查報告書 > 醫療設備

體外診斷

血液腫瘤檢測市場規模、佔有率和成長分析：按檢測類型、技術、癌症適應症、最終用戶、銷售管道和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2064995

血液腫瘤檢測市場規模、佔有率和成長分析：按檢測類型、技術、癌症適應症、最終用戶、銷售管道和地區分類－2026-2033年產業預測

Hemato Oncology Testing Market Size, Share, and Growth Analysis, By Test Type (Molecular Testing, Cytogenetics), By Technology Focus, By Cancer Indication, By End-User, By Sales Channel, By Region - Industry Forecast 2026-2033

出版日期: 2026年06月09日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球血液腫瘤檢測市場價值為 47 億美元，預計到 2025 年將成長至 53.3 億美元，到 2033 年將成長至 145.8 億美元，在預測期（2026-2033 年）內複合年成長率為 13.4%。

由於血液骨髓惡性腫瘤率的上升以及分子診斷和精準醫療技術的進步，全球血液腫瘤檢測市場正經歷顯著成長。該市場涵蓋多種調查方法對於檢測和後續觀察白血病、淋巴瘤和骨髓瘤等血液系統癌症至關重要，包括流式細胞技術、次世代定序、細胞遺傳學和伴隨診斷。及時且準確的檢測能夠實現個人化治療，從而改善患者預後並有可能降低長期成本。標靶治療與生物標記檢測之間的協同作用是成長要素，這促使人們使用綜合檢測方案並增加對先進檢測技術的投資。此外，人工智慧在診斷中的應用透過先進的數據分析提高了準確性，從而最佳化了臨床決策並簡化了工作流程。

全球血液系統惡性腫瘤檢測市場按檢測類型、技術重點、癌症適應症、最終用戶、銷售管道和地區進行細分。按檢測類型分類，市場分為分子檢測、細胞遺傳學、免疫組織化學、流式細胞技術和其他檢測。依技術重點分類，市場分為次世代定序、聚合酵素鏈鎖反應(PCR)、螢光雜合反應(FISH) 和其他技術。依癌症適應症分類，市場分為白血病、淋巴瘤、多發性骨髓瘤和其他癌症。依最終用戶分類，市場分為專科醫院、診斷檢測實驗室、研究機構和其他機構。依銷售管道分類，市場分為直接銷售給醫療機構、診斷試劑盒分銷商和其他管道。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球血液惡性腫瘤檢測市場的成長要素

全球血液系統惡性腫瘤檢測市場的發展主要得益於分子診斷技術的顯著進步，這些技術提高了骨髓惡性腫瘤的特異性和敏感性。這些技術進步透過穩定診斷流程並增強臨床醫生對患者預後的信心，加速了其在臨床實踐中的應用。改進的檢測設計以及與實驗室資訊系統的無縫整合，簡化了檢體處理和報告流程，鼓勵醫療機構更頻繁地採用先進的檢測方法。這種應用的增加不僅滿足了對先進診斷解決方案日益成長的需求，也推動了市場成長，並凸顯了創新在改善血液學相關醫療保健方面發揮的關鍵作用。

全球血液腫瘤檢測市場的限制因素

血液腫瘤檢測的複雜性及其相關的營運成本給全球血液腫瘤檢測市場帶來了巨大挑戰。這種複雜性常常阻礙了這些先進檢測方法的廣泛應用，因為許多檢查室難以實施必要的流程。對高技能人員、專用設備和嚴格品管規程的需求增加了日常營運的負擔，使得小規模的機構不願提供全面的檢測項目。持續的採購、員工培訓和維護需求造成了沉重的營運負擔，這可能會阻礙先進診斷服務的發展，並限制能夠提供這些必要檢測的檢查室數量。

全球血液惡性腫瘤檢測市場趨勢

全球血液學和腫瘤學檢測市場正經歷著向人工智慧驅動的診斷的重大轉變，這徹底改變了該領域的檢測工作流程。機器學習和先進影像分析的融合提高了診斷的一致性，並加快了複雜檢測結果的解讀。這些技術簡化了報告流程，並透過識別人工分析可能忽略的細微模式，加速了關鍵觀察的識別。因此，臨床治療方法的選擇決策品質得到了提升。這種模式轉移促進了檢查室和臨床團隊之間的合作，同時也增加了對可互通資料平台的需求。此外，這也為供應商提供了開發專門針對血液學和腫瘤學應用的、檢驗且可解釋的演算法的機會。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Roche
Abbott Laboratories
Thermo Fisher Scientific
Illumina
Invivoscribe
Qiagen
Bio-Rad Laboratories
Adaptive Biotechnologies
Exact Sciences
NeoGenomics
Asuragen
ARUP Laboratories
Quest Diagnostics
Labcorp
Sysmex
ArcherDX
Invitae
Myriad Genetics
Personalis
Nanostring Technologies

結論與建議

簡介目錄

Product Code: SQMIG35A3811

Global Hemato Oncology Testing Market size was valued at USD 4.7 Billion in 2024 and is poised to grow from USD 5.33 Billion in 2025 to USD 14.58 Billion by 2033, growing at a CAGR of 13.4% during the forecast period (2026-2033).

The global hemato-oncology testing market is experiencing significant growth due to the rising incidence of hematologic malignancies and advancements in molecular diagnostics and precision medicine. This landscape includes diverse diagnostic methodologies such as flow cytometry, next-generation sequencing, cytogenetics, and companion diagnostics-essential for the detection and monitoring of blood cancers like leukemia, lymphoma, and myeloma. Timely and accurate detection enables tailored treatments that enhance patient outcomes while potentially reducing long-term costs. A pivotal growth driver is the synergistic relationship between targeted therapies and biomarker testing, prompting the use of comprehensive panels and spurring investments in advanced laboratory technologies. Furthermore, the integration of AI in diagnostics enhances accuracy through improved data analysis, facilitating better decision-making and streamlined workflows within clinical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemato Oncology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemato Oncology Testing Market Segments Analysis

The global hemato oncology testing market is segmented by test type, technology focus, cancer indication, end-user, sales channel and region. Based on test type, the market is segmented into Molecular Testing, Cytogenetics, Immunohistochemistry, Flow Cytometry and Others. Based on technology focus, the market is segmented into Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization and Others. Based on cancer indication, the market is segmented into Leukemia, Lymphoma, Multiple Myeloma and Others. Based on end-user, the market is segmented into Specialized Hospitals, Diagnostic Laboratories, Research Institutes and Others. Based on sales channel, the market is segmented into Direct Institutional Sales, Diagnostic Kit Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemato Oncology Testing Market

The Global Hemato Oncology Testing market is propelled by significant advancements in molecular diagnostics that enhance the specificity and sensitivity of tests for hematologic malignancies. These technological improvements foster greater clinical adoption, as they stabilize diagnostic workflows and boost clinician confidence in patient outcomes. Enhanced assay designs and seamless integration with laboratory information systems streamline sample processing and reporting, encouraging healthcare providers to incorporate advanced testing more frequently. This increased utilization not only satisfies the growing need for sophisticated diagnostic solutions but also catalyzes market expansion, highlighting the essential role of innovation in improving hematology-related healthcare.

Restraints in the Global Hemato Oncology Testing Market

The intricate nature of hemato-oncology assays and the associated operational expenses pose significant challenges for the Global Hemato-Oncology Testing market. This complexity often hinders the widespread adoption of these advanced testing methods, as many laboratories find it difficult to implement the necessary workflows. The need for highly skilled personnel, specialized instrumentation, and rigorous quality control protocols places added pressure on routine operations, leading smaller facilities to hesitate in offering comprehensive testing panels. The ongoing requirements for procurement, staff training, and maintenance create substantial operational commitments, which can impede the growth of sophisticated diagnostic services and limit the number of laboratories capable of providing these essential tests.

Market Trends of the Global Hemato Oncology Testing Market

The global Hemato Oncology Testing market is witnessing a significant trend towards AI-enabled diagnostics, which is revolutionizing the testing workflows in the field. The integration of machine learning and advanced image analysis is enhancing diagnostic consistency and accelerating the interpretation of complex assays. By identifying subtle patterns often overlooked by human analysis, these technologies streamline reporting processes and expedite the identification of critical findings, thereby facilitating better decision-making for clinical therapy choices. This paradigm shift fosters collaboration between laboratories and clinical teams while elevating the demand for interoperable data platforms. Furthermore, it provides opportunities for vendors to develop validated, explainable algorithms tailored for hematologic and oncologic applications.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Hemato Oncology Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Molecular Testing
Cytogenetics
Immunohistochemistry
Flow Cytometry
Others

Global Hemato Oncology Testing Market Size by Technology Focus & CAGR (2026-2033)

Market Overview
Next-Generation Sequencing
Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Others

Global Hemato Oncology Testing Market Size by Cancer Indication & CAGR (2026-2033)

Market Overview
Leukemia
Lymphoma
Multiple Myeloma
Others

Global Hemato Oncology Testing Market Size by End-User & CAGR (2026-2033)

Market Overview
Specialized Hospitals
Diagnostic Laboratories
Research Institutes
Others

Global Hemato Oncology Testing Market Size by Sales Channel & CAGR (2026-2033)

Market Overview
Direct Institutional Sales
Diagnostic Kit Distributors
Others

Global Hemato Oncology Testing Market Size & CAGR (2026-2033)

North America (Test Type, Technology Focus, Cancer Indication, End-User, Sales Channel)
- US
- Canada
Europe (Test Type, Technology Focus, Cancer Indication, End-User, Sales Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Technology Focus, Cancer Indication, End-User, Sales Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Technology Focus, Cancer Indication, End-User, Sales Channel)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Technology Focus, Cancer Indication, End-User, Sales Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invivoscribe
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Adaptive Biotechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exact Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoGenomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asuragen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARUP Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArcherDX
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Personalis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanostring Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments